Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
120
NCT01855048
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 6, 2013
Completion: Feb 7, 2014
NCT03089697
Phase IIa Clinical Study of N-Rephasin® SAL200
Phase: Phase 2
Start: Mar 7, 2017
Completion: Nov 7, 2019
NCT03446053
A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers
Start: Feb 7, 2018
Completion: Feb 7, 2019
NCT03585803
A Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of KMRC011
Start: Jun 11, 2018
Completion: Nov 28, 2019